The track category is the heading under which your abstract will be reviewed and later published in the conference printed matters if accepted. During the submission process, you will be asked to select one track category for your abstract.
Pharmacology is the part of science worried about the investigation of medication action, where a medication can be comprehensively characterized as any man-made, regular, or endogenous (from inside the body) particle which applies a biochemical or physiological impact on the cell, tissue, organ, or life. All the more explicitly, it is the investigation of the associations that happen between a living life form and synthetic concoctions that influence ordinary or unusual biochemical capacity. In the event that substances have restorative properties, they are viewed as pharmaceuticals.
- Track 1-1mHealth sensors
- Track 1-2Validation rules, User acceptance testing
- Track 1-3Medicine development and safety testing
- Track 1-4Drug legislation and safety
- Track 1-5Clinical pharmacology
- Track 1-6Neuropharmacology
- Track 1-7Psychopharmacology
- Track 1-8Cardiovascular pharmacology
- Track 1-9Pharmacogenetics
- Track 1-10Pharmacogenomics
- Track 1-11Pharmacoepidemiology
Drug discovery and development together are the complete process of identifying a new drug and bringing it to market. Discovery may involve screening of chemical libraries, identification of the active ingredient from a natural remedy or design resulting from an understanding of the target. Development includes studies on microorganisms and animals, clinical trials and ultimately regulatory approval.
- Track 2-1Drug Design
- Track 2-2Drug Delivery
- Track 2-3Novel Approaches in Drug Discovery, Design, Development and Delivery
- Track 2-4Drug Metabolism
- Track 2-5Screening and design
- Track 2-6Chemical diversity
- Track 2-7Pre-clinical development
- Track 2-8Microbial metabolites & Marine invertebrates
Pharmacokinetics is the study of how a drug is absorbed, distributed, metabolized, and excreted over time.
Pharmacodynamics is the study of how a drug affects its target(s) in a dose- and time-dependent fashion.
- Track 3-1Pharmacokinetic models
- Track 3-2Bioavailability
- Track 3-3Clinical pharmacokinetics
- Track 3-4Multicellular pharmacodynamics
- Track 3-5Toxicodynamics
- Track 3-6Drug interactions and pharmacological compatibilities
- Track 3-7Clinical efficacy and safety evaluation
- Track 3-8Receptor theory for drug effects
Bioavailability is the degree and rate at which a substance (such as a drug) is absorbed into a living system or is made available at the site of physiological activity. Bioavailability is an essential measurement tool since it determines the correct dosage for non-intravenous administration of a drug. In clinical research trials, the bioavailability of a drug is a key factor to be measured in Phase 1 and Phase 2 trials.
Bioequivalence is the property wherein two drugs with identical active ingredients or two different dosage forms of the same drug possess similar bioavailability and produce the same effect at the site of physiological activity. Bioequivalence is determined by pharmacokinetic studies to determine whether a commercially available brand product and a potential to market generic version share core attributes. Determining the absolute bioavailability of a drug is done through a pharmacokinetic study.
- Track 4-1Bioavailability of drugs versus dietary supplements
- Track 4-2Nutritional science: reliable and universal bioavailability
- Track 4-3Bioavailability in pharmacology
- Track 4-4Bioavailability in nutritional sciences
- Track 4-5Bioavailability environmental sciences
- Track 4-6Absolute bioavailability
- Track 4-7Relative bioavailability and bioequivalence
- Track 4-8Factors influencing bioavailability
Toxicology is a study that involve an understanding of chemical properties and their actions on the body but differ considerably in other areas. Toxicology is the scientific study of adverse effects that occur in living organisms due to chemicals.
It involves observing and reporting symptoms, mechanisms, detection and treatments of toxic substances, in particular relation to the poisoning of humans. It includes environmental agents and chemical compounds found in nature, as well as pharmaceutical compounds that are synthesized for medical use by humans. These substances may produce toxic effects in living organisms including disturbance in growth patterns, discomfort, disease and death.
- Track 5-1Regulatory toxicology
- Track 5-2Toxicokinetic
- Track 5-3Toxicologic Pathology
- Track 5-4Plant toxicology
- Track 5-5Emergent Contaminants
- Track 5-6Medical toxicology
- Track 5-7Clinical toxicology
Pharmacovigilance is defined as the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem. Pharmacovigilance heavily focuses on adverse drug reactions, or ADRs, which are defined as any response to a drug which is noxious and unintended, including lack of efficacy.
- Track 6-1Evaluate the safety of drug and therapeutic biologic products
- Track 6-2Analyse safety signals
- Track 6-3Recommend regulatory actions
- Track 6-4Communicate relevant safety information
- Track 6-5Adverse event reporting
- Track 6-6Individual Case Safety Report
- Track 6-7Pharmacoepidemiology
Trials to evaluate the effectiveness and safety of medications or medical devices by monitoring their effects on large groups of people. Clinical research trials may be conducted by government health agencies such as NIH, researchers affiliated with a hospital or university medical program, independent researchers, or private industry. Usually volunteers are recruited, although in some cases research subjects may be paid. Subjects are generally divided into two or more groups, including a control group that does not receive the experimental treatment, receives a placebo (inactive substance) instead, or receives a tried-and-true therapy for comparison purposes.
Clinical research is a branch of healthcare science that determines the safety and effectiveness (efficacy) of medications, devices, diagnostic products and treatment regimens intended for human use. These may be used for prevention, treatment, diagnosis or for relieving symptoms of a disease. Clinical research is different from clinical practice. In clinical practice established treatments are used, while in clinical research evidence is collected to establish a treatment.
- Track 7-1Interventional clinical trials
- Track 7-2Observational clinical trials
- Track 7-3Phases of Trial
- Track 7-4Treatment trials
- Track 7-5Genetics trials
- Track 7-6Quality of Life trials
- Track 7-7Screening trials
Pharmacognosy is the study of the physical, chemical, biochemical and biological properties of drugs, drug substances or potential drugs or drug substances of natural origin as well as the search for new drugs from natural sources. Plant preparations are said to be medicinal or herbal when they are used to promote health beyond basic nutrition.
Phytochemistry is the study of phytochemicals, which are chemicals derived from plants. Those studying phytochemistry strive to describe the structures of the large number of secondary metabolic compounds found in plants, the functions of these compounds in human and plant biology, and the biosynthesis of these compounds.
- Track 8-1Constituents and drug synergism
- Track 8-2Herb and Drug Interactions
- Track 8-3marine pharmacognosy
- Track 8-4phytochemicals
- Track 8-5ethnopharmacology
- Track 8-6Herb and drug interactions
- Track 8-7Eastern Medicine
Pharmaceutical formulation, in pharmaceutics, is the process in which different chemical substances, including the active drug, are combined to produce a final medicinal product. The word formulation is often used in a way that includes dosage form. Formulation studies involve developing a preparation of the drug which is both stable and acceptable to the patient. For orally administered drugs, this usually involves incorporating the drug into a tablet or a capsule. It is important to make the distinction that a tablet contains a variety of other potentially inert substances apart from the drug itself, and studies have to be carried out to ensure that the encapsulated drug is compatible with these other substances in a way that does not cause harm, whether direct or indirect.
Drug manufacturing is the process of industrial-scale synthesis of pharmaceutical drugs by pharmaceutical companies. The process of drug manufacturing can be broken down into a series of unit operations, such as milling, granulation, coating, tablet pressing, and others.
- Track 9-1Enteral/gastrointestinal
- Track 9-2Prontosil, Penicillin and vaccines
- Track 9-3Lyophilized drugs
- Track 9-4Liquid drugs
- Track 9-5Oral administration
- Track 9-6Thalidomide
- Track 9-7Inhalation
Pharmaceutical Biotechnology can be defined as the science that covers all technologies required for the production, manufacturing and registration of biological drugs. It mainly works on to design, produce drugs that are adapted to each person’s genetic makeup, which can give the maximum therapeutic effect. Biotechnology plays an important role in pharmaceutical science most especially in the pharmaceutical industries by creation of genetically modified organisms that can be used in industrial production.
- Track 10-1Gene therapy
- Track 10-2Biosimilars
- Track 10-3Stem cell therapy
- Track 10-4Monoclonal antibodies, Haematopoietic growth factors, Interferons & Interleukin
- Track 10-5Human blood clotting factors
- Track 10-6Transgenic farm animals
- Track 10-7Artemisinin
- Track 10-8Human growth hormone
- Track 10-9Passive Immunization
- Track 10-10Human Reproductive Cells
Pharmaceutical innovations are currently guided by a patent system, the patent system protects the innovator of medicines for a period of time. The patent system does not currently stimulate innovation or pricing that provides access to medicine for those who need it the most, it provides for profitable innovation. As of 2014, research and development of pharmaceuticals which produces 25-35 new drugs. Technology, which is transforming science, medicine, and research tools has increased the speed at which we can analyse data, but we currently still must test the products which is a lengthy process. Differences in the performance of medical care may be due to variation in the introduction and circulation of pharmaceutical innovations.
- Track 11-1Generic Drug
- Track 11-2Precision medicine
- Track 11-3Artificial intelligence
- Track 11-43D printing
- Track 11-5mHealth sensors
Clinical Data Management (CDM) is a critical phase in clinical research, which leads to generation of high-quality, reliable, and statistically sound data from clinical trials. This helps to produce a drastic reduction in time from drug development to marketing. Team members of CDM are actively involved in all stages of clinical trial right from inception to completion.
- Track 12-1Standard operating procedures
- Track 12-2Data management plan
- Track 12-3Database design and build
- Track 12-4Data entry, Data validation, Data Queries
- Track 12-5Serious adverse event reconciliation
- Track 12-6Quality control
- Track 12-7Patient recorded data
The method by which a drug is delivered can have a significant effect on its efficacy. Some drugs have an optimum concentration range within which maximum benefit is derived, and concentrations above or below this range can be toxic or produce no therapeutic benefit at all. On the other hand, the very slow progress in the efficacy of the treatment of severe diseases, has suggested a growing need for a multidisciplinary approach to the delivery of therapeutics to targets in tissues. From this, new ideas on controlling the pharmacokinetics, pharmacodynamics, non-specific toxicity, immunogenicity, biorecognition, and efficacy of drugs were generated. These new strategies, often called drug delivery systems (DDS), are based on interdisciplinary approaches that combine polymer science, pharmaceutics, bioconjugate chemistry, and molecular biology.
- Track 13-1Drug Delivery Systems
- Track 13-2Drug Delivery Carriers
- Track 13-3Administration Routes
- Track 13-4Future Opportunities and Challenges
Nanomedicine is a branch of medicine that applies the knowledge and tools of nanotechnology to the prevention and treatment of disease. Nanomedicine involves the use of nanoscale materials, such as biocompatible nanoparticles and nanorobots, for diagnosis, delivery, sensing or actuation purposes in a living organism.
Nanotechnology is the science of manipulating materials on an atomic or molecular scale specially to build microscopic devices (such as robots).
- Track 14-1Drug Delivery
- Track 14-2Nanosensor
- Track 14-3Blood Purification
- Track 14-4Tissue Engineering
- Track 14-5Molecular Nanotechnology
- Track 14-6Regulation of Nanotechnology
- Track 14-7Implications of Nanotechnology
- Track 14-8Functional Approaches
- Track 14-9Biomimetic Approaches
Regulatory affairs are a comparatively new profession which developed from the desire of governments to protect public health by controlling the safety and efficacy of products in areas including pharmaceuticals, veterinary medicines, medical devices, pesticides, agrochemicals, cosmetics and complementary medicines. The companies responsible for the discovery, testing, manufacture and marketing of these products also want to ensure that they supply products that are safe and make a worthwhile contribution to public health and welfare.
Intellectual property rights refer to the general term for the assignment of property rights through patents, copyrights and trademarks. These property rights allow the holder to exercise a monopoly on the use of the item for a specified period. By restricting imitation and duplication, monopoly power is conferred, but the social costs of monopoly power may be offset by the social benefits of higher levels of creative activity encouraged by the monopoly earnings.
- Track 15-1Pharmaceuticals
- Track 15-2Medical devices
- Track 15-3Patent infringement
- Track 15-4Biologics and Biotechnology
- Track 15-5in-vitro diagnostics
- Track 15-6Nutritional products